MapLight Therapeutics is a clinical stage biotech company that focuses on drug discovery for central nervous system disorders. They combine cutting-edge technologies including optogenetics, in vivo physiology, and spatial transcriptomics to identify novel drug targets and develop effective therapies to address psychiatric symptoms.